The use of benzodiazpines and related drugs amongst older people in Sweden: Associated factors and concomitant use of other psychotropics

被引:54
作者
Johnell, Kristina [1 ]
Fastbom, Johan [1 ]
机构
[1] Karolinska Inst, Aging Res Ctr, S-11330 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
benzodiazepines; elderly; pharmacoepidemiology; psychotropic drugs; register-based research; BENZODIAZEPINE USE; CONSENSUS PANEL; COGNITIVE FUNCTION; HIP-FRACTURES; ZOLPIDEM; COMMUNITY; HYPNOTICS; ZOPICLONE; RISK; INSOMNIA;
D O I
10.1002/gps.2189
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective To determine the factors associated with use of benzodiazepines and benzodiazepine related drugs (BZDs/BZDRDs) in a nationwide population of older people. Methods We analyzed data on age, sex, type of residential area (urban/rural), and dispensed drugs for people aged >= 75 years registered in the Swedish Prescribed Drug Register from October to December 2005 (n = 731 105; corresponds to 91% of the domain population). Multivariate logistic regression analysis was used for analyzing whether age, sex, type of residential area, number of other drugs, and concomitant psychotropic drug use was associated with use of BZDs/BZDRDs. Results >= 1 BZDs/BZDRDs and >= 2 BZDs/BZDRDs were used by 25% and 5% of the study population, respectively. The most commonly used BZDs/BZDRDs were zopiclone, zolpidem, oxazepam, flunitrazepam, and diazepam. The probability of use BZDs/BZDRDs increased with age, female gender, living in an urban area, use of many other drugs, and concomitant use of other psychotropics, particularly antidepressants. In the comparisons of different BZDs/BZDRDs (n = 179 632), the medium-acting BZDs were associated with higher age, female gender, and use of other psychotropics, whereas BZDRDs showed the opposite pattern. Also, the two BZDRDs zopiclone and zolpidem showed different patterns regarding age, sex, and use of other drugs. Conclusions One in four of the elderly used one or more BZD/BZDRD, which should be prescribed cautiously and with the recognition of the potentially negative effects. There were differences in patterns of use for different BZDs/BZDRDs, even within the same drug class. Hence, large study populations are needed for future research of individual BZDs/BZDRDs. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:731 / 738
页数:8
相关论文
共 52 条
[1]   Association of road-traffic accidents with benzodiazepine use [J].
Barbone, F ;
McMahon, AD ;
Davey, PG ;
Morris, AD ;
Reid, IC ;
McDevitt, DG ;
MacDonald, TM .
LANCET, 1998, 352 (9137) :1331-1336
[2]   Use of benzodiazepines among elderly patients [J].
Bogunovic, OJ ;
Greenfield, SF .
PSYCHIATRIC SERVICES, 2004, 55 (03) :233-235
[3]   Delirium associated with zolpidem [J].
Brodeur, MR ;
Stirling, AL .
ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) :1562-1564
[4]   Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan [J].
Cheng, Jur-Shan ;
Huang, Weng-Foung ;
Lin, Keh-Ming ;
Shih, Yaw-Tang .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (06) :618-624
[5]  
Cimolai N, 2007, CAN FAM PHYSICIAN, V53, P2124
[6]   BENZODIAZEPINES AND THE ELDERLY - A REVIEW OF POTENTIAL PROBLEMS [J].
CLOSSER, MH .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1991, 8 (1-2) :35-41
[7]   Benzodiazepines and risk of hip fractures in older people - A review of the evidence [J].
Cumming, RG ;
Le Couteur, DG .
CNS DRUGS, 2003, 17 (11) :825-837
[8]   Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives - Zaleplon, zolpidem and zopiclone [J].
Drover, DR .
CLINICAL PHARMACOKINETICS, 2004, 43 (04) :227-238
[9]   Updating the beers criteria for potentially inappropriate medication use in older adults - Results of a US consensus panel of experts [J].
Fick, DM ;
Cooper, JW ;
Wade, WE ;
Waller, JL ;
Maclean, JR ;
Beers, MH .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (22) :2716-2724
[10]   Benzodiazepine use in an elderly community-dwelling population -: Characteristics of users and factors associated with subsequent use [J].
Fourrier, A ;
Letenneur, L ;
Dartigues, JF ;
Moore, N ;
Bégaud, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (05) :419-425